IP Verse

Modified Nucleosides, Nucleotides, And Nucleic Acids, And Uses Thereof

PatentPatent Analysis

EP3492109

MODERNA THERAPEUTICS
Application Number
EP18213451A
Filing Date
Oct 3, 2012
Status
Revoked
Aug 18, 2023
Grant Date
Mar 4, 2020
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP2791160B1
EP2922554B1
EP3019619B1

Biblio Summary

The patent EP3492109B1 was granted to Moderna Therapeutics on Mar 4, 2020 following the initial filing on Oct 3, 2012 under the application number EP18213451A . The current legal status of the patent is Revoked.

AI Generated Summary New

Patent Family

Patent Oppositions filed by Competitors

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

BIONTECHDec 4, 2020ADMISSIBLE
SANOFIDec 4, 2020ADMISSIBLE

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents